PressDigest

Valeant and Shire plot Salix takeover

Salix Pharmaceuticals, the US drugmaker with a market capitalisation of almost $10bn, is in talks with acquisitive Canadian rival Valeant Pharmaceuticals over potentially selling itself, The New York Times gathers.

WSJ Logo
Venture Debt Firms Tilt Toward Mature CompaniesExternal link

Venture Debt Firms Tilt Toward Mature Companies